RELIEF THERAPEUTICS Holding Ltd.

RLF

Equity

ISIN CH1251125998 / Valor 125112599

SIX Swiss Exchange (2025-12-19)

CHF 2.59+1.28%

RELIEF THERAPEUTICS Holding Ltd.
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

RELIEF THERAPEUTICS Holding Ltd. is a Swiss biopharmaceutical company focused on identifying, developing, and commercializing novel, patent-protected products in specialty, rare, and ultra-rare disease areas worldwide. The company is currently in the commercial-stage and is dedicated to bringing innovative treatments to patients in need.

Summarized from source with an LLMView SourceSector: Technology

Operational Achievements

The Annual Report underscores a series of operational milestones that have strengthened the company’s foundation, setting the stage for further progress in its specialty and rare disease treatment efforts throughout 2024.

Pipeline Advancements

Key candidates such as RLF-OD032 for phenylketonuria and RLF-TD011 for epidermolysis bullosa have made significant strides, reflecting the company’s commitment to expanding its portfolio with innovative treatment options.

Strengthened Financial Position

RELIEF THERAPEUTICS Holding Ltd.’s report emphasizes its improved financial standing, which supports continued investments in clinical development and commercial strategies, ultimately contributing to the company’s long-term growth and sustainability.

Summarized from source with an LLMView Source

Key figures

-32.6%1Y

-76.5%3Y

-98.2%5Y

Performance

81.4%1Y

87.6%3Y

93.1%5Y

Volatility